4D pharma (LBPSW) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock LBPSW vs. ATNFW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, CELUW, and CINGWShould you be buying 4D pharma stock or one of its competitors? The main competitors of 4D pharma include 180 Life Sciences (ATNFW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), Celularity (CELUW), and Cingulate (CINGW). These companies are all part of the "pharmaceutical products" industry. 4D pharma vs. Its Competitors 180 Life Sciences Aesther Healthcare Acquisition Ainos Alvotech Atlantic Coastal Acquisition Corp. II Biofrontera biote BriaCell Therapeutics Celularity Cingulate 180 Life Sciences (NASDAQ:ATNFW) and 4D pharma (NASDAQ:LBPSW) are both pharmaceutical products companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, media sentiment, risk, earnings, valuation, institutional ownership and dividends. Which has better valuation & earnings, ATNFW or LBPSW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio180 Life SciencesN/AN/AN/AN/AN/A4D pharma$522KN/AN/AN/AN/A Does the media refer more to ATNFW or LBPSW? In the previous week, 180 Life Sciences had 5 more articles in the media than 4D pharma. MarketBeat recorded 5 mentions for 180 Life Sciences and 0 mentions for 4D pharma. 180 Life Sciences' average media sentiment score of 0.98 beat 4D pharma's score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the media. Company Overall Sentiment 180 Life Sciences Positive 4D pharma Neutral Is ATNFW or LBPSW more profitable? Company Net Margins Return on Equity Return on Assets 180 Life SciencesN/A N/A N/A 4D pharma N/A N/A N/A Summary180 Life Sciences beats 4D pharma on 2 of the 3 factors compared between the two stocks. Get 4D pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for LBPSW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LBPSW vs. The Competition Export to ExcelMetric4D pharmaPharmaceutical Preparation Manufacturing IndustryManufacturing SectorNASDAQ ExchangeMarket CapN/AN/A$2.54B$9.84BDividend YieldN/AN/A2.56%4.07%P/E RatioN/AN/A22.1925.74Price / SalesN/AN/A86.78115.83Price / CashN/AN/A23.7359.48Price / BookN/AN/A33.046.15Net IncomeN/AN/A$31.01M$265.06M 4D pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LBPSW4D pharmaN/AN/AN/AN/A$0.00$522K0.00N/AATNFW180 Life SciencesN/A$0.01+22.0%N/A+4,239.6%$0.00N/A0.007News CoverageHigh Trading VolumeAEHAWAesther Healthcare AcquisitionN/A$0.01+84.9%N/AN/A$0.00N/A0.002Gap DownAIMDWAinosN/A$0.29+16.0%N/AN/A$0.00$106.21K0.0040Gap UpALVOWAlvotechN/A$1.27flatN/A-52.4%$0.00$585.60M0.004Gap UpACABWAtlantic Coastal Acquisition Corp. IIN/A$0.05+2.9%N/AN/A$0.00N/A0.0015Gap UpBFRIWBiofronteraN/A$0.14-9.9%N/AN/A$0.00$38.00M0.0070Gap DownBTMDWbioteN/A$0.02flatN/AN/A$0.00$199.38M0.00N/AGap UpBCTXWBriaCell TherapeuticsN/A$0.03-1.7%N/A-85.8%$0.00N/A0.008Negative NewsShort Interest ↓Gap DownHigh Trading VolumeCELUWCelularityN/A$0.05+11.6%N/AN/A$0.00$54.22M0.00220News CoveragePositive NewsGap DownCINGWCingulateN/A$0.07-11.4%N/A+398.5%$0.00N/A0.0020Gap Up Related Companies and Tools Related Companies 180 Life Sciences Competitors Aesther Healthcare Acquisition Competitors Ainos Competitors Alvotech Competitors Atlantic Coastal Acquisition Corp. II Competitors Biofrontera Competitors biote Competitors BriaCell Therapeutics Competitors Celularity Competitors Cingulate Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LBPSW) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 4D pharma plc Please log in to your account or sign up in order to add this asset to your watchlist. Share 4D pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access